Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
![(1S)-1-[3-[3-[(Dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl P,P-bis(1-aziridinyl)phosphinate](https://www.pharmacompass.com/image/drug/134817236.png)
![(1S)-1-[3-[3-[(Dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl P,P-bis(1-aziridinyl)phosphinate](https://www.pharmacompass.com/image/drug/134817236.png)
1. Ast-3424
2. 2097713-69-2
3. Odafosfamide
4. Odafosfamide [inn]
5. Schembl20870082
6. Schembl29392358
7. C2t9s468d3
8. Ex-a6317
9. Obi-3424, (s)-
10. Th-2870, (s)-
11. (1s)-1-{3-[3-(dimethylcarbamoyl)phenoxy]-4-nitrophenyl}ethyl Bis(aziridin-1-yl)phosphinate
12. 3-[5-[(1s)-1-[bis(aziridin-1-yl)phosphoryloxy]ethyl]-2-nitrophenoxy]-n,n-dimethylbenzamide
13. Phosphinic Acid, P,p-bis(1-aziridinyl)-, (1s)-1-[3-[3-[(dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl Ester
| Molecular Weight | 460.4 g/mol |
|---|---|
| Molecular Formula | C21H25N4O6P |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 108 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 737 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE